Jonathan Block
Stock Analyst at Stifel Nicolaus
(4.11)
# 1,656
Out of 4,634 analysts
623
Total ratings
51.3%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintained: Hold | $14 | $11.66 | +20.07% | 44 | Aug 7, 2026 | |
| ZTS Zoetis | Maintained: Hold | $85 | $74.83 | +13.59% | 59 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $22 | $22.81 | -3.55% | 5 | Aug 7, 2026 | |
| PODD Insulet | Rated: Buy | $225 → $180 | $142.85 | +26.01% | 7 | Aug 6, 2026 | |
| TRUP Trupanion | Reiterated: Hold | $28 | $29.06 | -3.65% | 44 | Aug 6, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $31 | $28.19 | +9.97% | 25 | Aug 6, 2026 | |
| NYXH Nyxoah | Reiterated: Hold | $3 | $1.58 | +89.87% | 38 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $84 → $95 | $88.08 | +7.86% | 34 | Aug 5, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $65 → $75 | $59.72 | +25.59% | 41 | Aug 4, 2026 | |
| DXCM DexCom | Rated: Buy | $90 → $95 | $87.65 | +8.39% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $22.28 | +43.63% | 41 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $176.04 | +19.29% | 104 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.40 | +21.95% | 7 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $675 | $595.76 | +13.30% | 67 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 | $220.05 | +6.79% | 11 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $76.32 | +11.37% | 36 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $7.54 | +6.10% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.64 | +212.50% | 17 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $0.8419 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $45 | $181.42 | n/a | 22 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 | $0.0002 | n/a | 1 | Jul 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $41 → $47 | $216.98 | n/a | 3 | May 15, 2017 |
DENTSPLY SIRONA
Aug 7, 2026
Maintained: Hold
Price Target: $14
Current: $11.66
Upside: +20.07%
Zoetis
Aug 7, 2026
Maintained: Hold
Price Target: $85
Current: $74.83
Upside: +13.59%
Tandem Diabetes Care
Aug 7, 2026
Maintained: Hold
Price Target: $22
Current: $22.81
Upside: -3.55%
Insulet
Aug 6, 2026
Rated: Buy
Price Target: $225 → $180
Current: $142.85
Upside: +26.01%
Trupanion
Aug 6, 2026
Reiterated: Hold
Price Target: $28
Current: $29.06
Upside: -3.65%
Envista Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $31
Current: $28.19
Upside: +9.97%
Nyxoah
Aug 6, 2026
Reiterated: Hold
Price Target: $3
Current: $1.58
Upside: +89.87%
Henry Schein
Aug 5, 2026
Maintained: Hold
Price Target: $84 → $95
Current: $88.08
Upside: +7.86%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Buy
Price Target: $65 → $75
Current: $59.72
Upside: +25.59%
DexCom
Jul 31, 2026
Rated: Buy
Price Target: $90 → $95
Current: $87.65
Upside: +8.39%
Jul 31, 2026
Reiterated: Hold
Price Target: $32
Current: $22.28
Upside: +43.63%
Jul 30, 2026
Maintained: Buy
Price Target: $210
Current: $176.04
Upside: +19.29%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $16.40
Upside: +21.95%
Jul 15, 2026
Maintained: Buy
Price Target: $675
Current: $595.76
Upside: +13.30%
Jul 8, 2026
Reiterated: Hold
Price Target: $235
Current: $220.05
Upside: +6.79%
Jun 12, 2026
Maintained: Buy
Price Target: $85
Current: $76.32
Upside: +11.37%
May 11, 2026
Maintained: Hold
Price Target: $9 → $8
Current: $7.54
Upside: +6.10%
Mar 13, 2026
Reiterated: Hold
Price Target: $2
Current: $0.64
Upside: +212.50%
Jan 7, 2022
Maintained: Buy
Price Target: $10 → $9
Current: $0.8419
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $55 → $45
Current: $181.42
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $41 → $47
Current: $216.98
Upside: n/a